Stock market today: The Indian stock market ended on a negative note on Tuesday, with the Sensex declining by 0.36% to reach 82,029.98, while the Nifty 50 decreased by 82 points, or 0.32%, to settle ...

Google began experimenting with conversational image editing earlier this year in the dev-focused AI studio, but the feature didn’t remain experimental for long. Over the summer, Google rolled out the ...

They sure know how to celebrate a win in Queensland, and there’s been a few big wins in recent weeks: First the Brisbane Lions won the AFL flag, and a week later the Brisbane Broncos snatched a ...

Nuclear energy and technology company NANO Nuclear Energy Inc has announced it is to invest more than USD12 million to establish a manufacturing and research and development facility in Illinois, with ...

GENEVA: The World Trade Organization sharply lowered its 2026 forecast for global merchandise trade volume growth to 0.5 per cent on Tuesday (Oct 7), citing expected delayed impacts from US President ...

Illinois will subsidize a new R&D facility for Nano Nuclear outside Chicago. Nano Nuclear will invest $12 million in the facility itself. The facility's primary aim will be to advance development of ...

Qualcomm (QCOM) announced plans to acquire Italian hardware and software developer Arduino, allowing the AI semiconductor manufacturer to lean heavier into the robotics market. Qualcomm group general ...

We recently published 10 Stocks Investors Are Gobbling Up. NANO Nuclear Energy Inc. (NASDAQ:NNE) is one of the top performers on Monday. NANO Nuclear extended its rally to a fourth consecutive session ...

Qualcomm plans to acquire open-source hardware and software player Arduino, a buy which will advance the US chip company’s goal to provide a full stack of services once customary closing conditions ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Nano Nuclear Energy (Nasdaq: NNE) is going vertical today ...

Series A financing will advance the company’s lead candidate for heart failure with reduced ejection fraction (HFrEF) through completion of early clinical development and GMP manufacturing scale-up ...